Key result
Inherited prothrombotic defects were detected in 28% of patients with Budd-Chiari syndrome and 15% of patients with portal vein thrombosis.
Why the study?
What is the prevalence of inherited prothrombotic defects in patients with Budd-Chiari syndrome and portal vein thrombosis in North India?
Observational (n=105)
What is the prevalence of inherited prothrombotic defects in patients with Budd-Chiari syndrome and portal vein thrombosis in North India?
Answers are grounded in this paper and cite their sources.
Inherited prothrombotic defects are present in a significant proportion of patients with Budd-Chiari syndrome and portal vein thrombosis in North India, with differing mutation profiles between the two conditions.
We studied 57 patients with Budd-Chiari syndrome (BCS) and 48 with portal vein thrombosis (PVT) for underlying inherited prothrombotic defects such as protein C, protein S, and antithrombin III deficiencies. Genetic mutations for factor V Leiden, prothrombin gene 20210A, and methyltetrahydrofolate reductase (MTHFR) C677T were studied in 29 patients in each group. Inherited prothrombotic defects were detected in 16 (28%) of 57 patients with BCS and 7 (15%) of 48 patients with PVT. Factor V Leiden mutation was the most common prothrombotic defect in BCS (5/29 [17%]) followed by protein C deficiency (7/57 [12%]) and protein S deficiency (4/57 [7%]), whereas in PVT, protein C deficiency was the most common inherited prothrombotic defect (4/48 [8%]) followed by protein S deficiency (2/48 [4%]). The factor V Leiden mutation was detected in only 1 (3%) of 29 cases of PVT. The heterozygous MTHFR C677T mutation was detected in 7 (24%) of 29 patients with BCS and 6 (21%) of 29 patients with PVT. Antithrombin III deficiency, homozygous MTHFR C677T mutation, and prothrombin G20210A mutation were not detected in any patients.
No takes yet. Share an insight, caveat, or question.
Bhattacharyya et al. (2004) conducted an observational in Budd-Chiari syndrome and portal vein thrombosis (n=105). Budd-Chiari syndrome vs. Portal vein thrombosis was evaluated on Detection of inherited prothrombotic defects. Inherited prothrombotic defects were detected in 28% of patients with Budd-Chiari syndrome and 15% of patients with portal vein thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: